bigram

This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

bigram	frequency
clinical trials	553
clinical trial	264
adverse events	131
clinical research	125
controlled trial	102
acute respiratory	99
standard care	86
missing data	85
informed consent	85
systematic review	76
sample size	72
controlled trials	72
randomized controlled	70
randomised controlled	68
serious adverse	63
data collection	61
randomized clinical	60
coronavirus disease	59
public health	58
respiratory syndrome	57
cord uid	56
doc id	56
trial design	54
phase iii	53
health care	53
versus standard	51
phase i	51
negative disconfirmation	50
respiratory failure	49
mechanical ventilation	49
severe acute	48
phase ii	46
clinical practice	46
safety data	45
trial sequential	43
united states	43
healthcare workers	42
first trial	42
control group	41
respiratory distress	41
analysis showed	40
additional file	40
data will	39
treatment effect	39
novel coronavirus	39
participants will	39
distress syndrome	38
statistical analysis	38
trial results	38
trial will	38
cause mortality	36
will also	35
primary outcome	34
pharmaceutical companies	34
world health	34
action sequence	33
cancer patients	33
syndrome coronavirus	33
may also	33
low certainty	33
critically ill	33
medical research	33
statistical methods	33
health organization	32
twice daily	32
intensive care	32
developing countries	31
showed evidence	30
sequential analysis	30
systematic reviews	29
one trial	29
chronic obstructive	29
clinical study	28
pulmonary disease	28
trial participants	28
age groups	27
obstructive pulmonary	27
observational studies	27
outcome measures	27
ill patients	27
randomized trial	27
cognitive flexibility	27
patients will	26
action sequences	26
bubonic plague	26
trial emulation	26
trials may	26
breast cancer	26
drug administration	25
critical care	25
severe covid	25
data protection	25
institutional review	24
confidence interval	24
high risk	24
ethics committee	24
copd exacerbation	23
adverse event	23
living systematic	23
free days	23
secondary outcomes	23
infectious diseases	23
interim analysis	23
relative risk	23
within days	22
health research	22
exclusion criteria	22
beneficial effect	22
pneumonic plague	22
patient safety	22
steering committee	22
vaccine candidates	22
drug safety	21
study protocol	21
side effects	21
versus placebo	21
nonserious adverse	21
led trials	21
iii trials	21
trial designs	21
live home	21
will need	20
safety outcomes	20
inclusion criteria	20
study treatment	20
regulatory agencies	20
made available	20
mg kg	20
may need	20
lung injury	20
trial data	20
remdesivir versus	19
protocol deviations	19
lopinavir ritonavir	19
study design	19
will likely	19
cohort study	19
data quality	19
observational study	19
undue influence	19
care alone	18
significant difference	18
confirmed cases	18
scientific community	18
intervention period	18
medical management	18
randomized trials	18
human subjects	18
research team	18
case report	18
three age	18
good clinical	18
included trials	18
safety monitoring	18
acute lung	18
nasal obstruction	17
hand hygiene	17
risk reduction	17
ongoing clinical	17
trial registration	17
related ices	17
full protocol	17
copyright holder	17
care versus	17
will receive	17
ii trials	17
clinical studies	17
least one	16
tentative solution	16
primary endpoint	16
review boards	16
data management	16
medicines agency	16
group will	16
international license	16
total number	16
target trial	16
data sharing	16
individual patient	16
older adults	16
data analysis	16
treatment effects	16
hospitalized patients	16
pregnant women	16
granted medrxiv	15
two trials	15
information size	15
type i	15
chinese medicine	15
task demands	15
mask use	15
registered trials	15
social network	15
authors declare	15
com scientificreports	15
data verification	15
open access	15
test trials	15
research participation	15
research participants	15
convalescent plasma	15
peer review	15
author funder	15
interventional trials	15
miracle trial	15
mean difference	15
ongoing trials	15
primary outcomes	15
trials within	15
jacobson hopper	15
east respiratory	14
traditional chinese	14
data monitoring	14
social distancing	14
patient care	14
required information	14
preventive treatment	14
treatment arms	14
efficient solution	14
analysis will	14
systemic glucocorticoids	14
control trials	14
intermittent preventive	14
trial conduct	14
lung cancer	14
cancer clinical	14
pharmaceutical industry	14
drug development	14
path trial	14
live oral	14
adverse reactions	14
sponsored trials	14
risk factors	14
nonhuman primates	14
middle east	14
competing interests	14
interim analyses	14
resource utilization	14
dementia care	14
sample sizes	14
platform trials	13
source control	13
international clinical	13
tentative solutions	13
international conference	13
trial registries	13
analyses will	13
trials using	13
clinical improvement	13
external validity	13
living mapping	13
master protocols	13
eligibility criteria	13
european medicines	13
staff will	13
task configuration	13
trial completion	13
septal surgery	13
immune responses	13
trials conducted	13
trial integrity	13
acute exacerbation	13
take place	13
patient data	13
outcome measure	13
impact score	13
medical products	12
study visits	12
subgroup analyses	12
drug trials	12
clinical characteristics	12
olds used	12
phase iib	12
consent form	12
healthcare systems	12
infectious disease	12
compassionate use	12
information technology	12
investigators will	12
alongside genv	12
clinical data	12
social media	12
sick patients	12
remains neutral	12
adaptive trial	12
malarial drugs	12
respiratory syncytial	12
nature remains	12
institutional affiliations	12
urgent need	12
statistical monitoring	12
safety assessment	12
posted june	12
patient will	12
mental health	12
rheumatoid arthritis	12
large number	12
published maps	12
creative commons	12
springer nature	12
vaccine protection	12
trial participation	12
randomised trials	12
two groups	12
version posted	12
generation victoria	12
treatment group	12
recovery trial	12
jurisdictional claims	12
single trial	12
genv will	12
will include	12
olfactory information	12
analysis plan	12
publicly available	12
i error	12
trials will	12
clinical care	12
will take	11
preliminary report	11
supportive care	11
colorectal cancer	11
experimental group	11
hypothetical strategy	11
eligible patients	11
malarial drug	11
health emergency	11
trial randomizing	11
conducting clinical	11
good enough	11
study group	11
monitoring committee	11
vaccine trials	11
may lead	11
trials registered	11
based medicine	11
syncytial virus	11
enough information	11
clinical outcomes	11
note springer	11
randomized control	11
evidence base	11
treatment options	11
problem solving	11
patients treated	11
network meta	11
increased risk	11
use scenarios	11
grounded theory	11
performance status	11
potential treatments	11
blog posts	11
information systems	11
vaccine safety	11
early phase	11
multiple trials	11
two straws	11
ethical principles	11
sensitivity analysis	11
care unit	11
may include	11
enrolled patients	11
will provide	11
adaptive designs	11
vaccine development	11
trial sponsors	11
hydroxychloroquine versus	11
study designs	11
patients admitted	11
regulatory authorities	11
source data	11
days will	10
study will	10
disease severity	10
baseline characteristics	10
cancer care	10
ciprofloxacin mg	10
trial sites	10
treated states	10
data may	10
trials reported	10
forest plot	10
treatment arm	10
randomised clinical	10
review board	10
younger children	10
take part	10
research questions	10
risk ratio	10
respiratory disease	10
group sequential	10
clinical decision	10
research efforts	10
vaccine trial	10
respiratory viruses	10
adults hospitalized	10
children used	10
nasal septum	10
report form	10
adverse effects	10
analyses may	10
outcomes will	10
human research	10
supplementary information	10
scent trails	10
trials registry	10
high level	10
completed trials	10
control groups	10
future research	10
immune response	10
clinical development	10
site staff	10
research council	10
visual inspection	10
among patients	10
causal understanding	10
nursing home	10
developing world	10
animal models	10
new drug	10
across trials	10
sensitivity analyses	10
research ethics	10
quantify heterogeneity	10
month follow	10
statistical analyses	10
primary subspecialty	10
users may	10
turbinate reduction	9
study participants	9
randomised trial	9
electronic medical	9
new drugs	9
related missing	9
policy trial	9
research community	9
kg twice	9
principal investigator	9
severe bronchiolitis	9
coronavirus pandemic	9
author impact	9
risk assessment	9
research activities	9
exact test	9
health authorities	9
controlled clinical	9
research enterprise	9
determine whether	9
efficient responses	9
process evaluation	9
medical records	9
sunda pangolin	9
virus disease	9
registry platform	9
care workers	9
manis javanica	9
effect size	9
second trial	9
therapeutic response	9
results will	9
publication bias	9
tidal volumes	9
ards network	9
case study	9
efficient method	9
related missingness	9
european countries	9
implementation process	9
interferon alpha	9
commonly used	9
picu stay	9
central statistical	9
available data	9
monitoring board	9
trial protocols	9
national institutes	9
current covid	9
cancer research	9
weighted mean	9
phase trials	9
statistically significant	9
investigational products	9
chloroquine diphosphate	9
current pandemic	9
across multiple	9
ensemble modeling	9
small sample	9
medical masks	9
pooled analysis	9
health workers	9
research findings	9
hpa axis	9
us food	9
plaque psoriasis	9
home orders	9
sensory information	9
genv data	9
second stage	9
blood pressure	9
internal validity	8
many ways	8
written informed	8
drug use	8
residual odor	8
replacement therapy	8
index score	8
dead ants	8
alternative treatment	8
personal use	8
laboratory tests	8
control trial	8
empirical material	8
influenza infection	8
future trials	8
severe psoriasis	8
data entry	8
belmont report	8
care systems	8
nasal patency	8
one single	8
iii trial	8
primary endpoints	8
study population	8
day prednisone	8
prone positioning	8
identified trials	8
combination therapy	8
placebo group	8
time points	8
information accompanies	8
huashan hospital	8
rapid review	8
personal protective	8
controlled study	8
will allow	8
intervention group	8
collected data	8
north american	8
ebola virus	8
among others	8
cancer cells	8
consent process	8
control arm	8
viral infections	8
ritonavir versus	8
primary objective	8
trial steering	8
coronavirus pneumonia	8
per group	8
trial statistician	8
nasal airway	8
randomizing participants	8
site monitoring	8
target trials	8
protection regulation	8
natural history	8
cohort studies	8
olds made	8
based quality	8
icu patients	8
care services	8
data collected	8
research process	8
intravenous vitamin	8
site initiation	8
relevant data	8
test trial	8
southeast asia	8
therapeutic interventions	8
remote monitoring	8
trials doi	8
phase clinical	8
primary analysis	8
effects meta	8
case series	8
statistical power	8
face mask	8
intervention effects	8
treatment policy	8
two reviewers	8
phase trial	8
safety endpoints	8
study drug	8
treatment groups	8
integrative cancer	8
surfactant therapy	8
multiple imputation	8
orphan drug	8
mycophenolate mofetil	8
case reports	8
two containers	8
confidence intervals	8
quality management	8
eligible trials	8
data meta	8
ethics committees	8
research project	8
will require	8
six trials	8
olds versus	8
parallel group	8
adaptive clinical	8
jwby formulas	8
effective treatment	8
test phase	8
protective equipment	8
related disruptions	8
per protocol	7
subgroup analysis	7
trial recruitment	7
kluwer health	7
trial may	7
treating covid	7
per day	7
long term	7
surgical clinical	7
related factors	7
random errors	7
trial protocol	7
quality clinical	7
new vaccines	7
treatment will	7
review process	7
academic literature	7
exogenous surfactant	7
care system	7
information will	7
allocated treatment	7
observed data	7
study coordinators	7
unauthorized reproduction	7
bayesian adaptive	7
renal replacement	7
rare disease	7
time zero	7
zika virus	7
go beyond	7
prostate cancer	7
decision makers	7
will make	7
data safety	7
adjusted required	7
research question	7
additional analyses	7
might also	7
intervention will	7
recent years	7
severe disease	7
participant safety	7
error behaviour	7
malaria prevention	7
protocol amendments	7
first days	7
involving human	7
tolerable errors	7
caregiver burden	7
trials randomizing	7
cloth masks	7
i trials	7
monitoring boundaries	7
reviewed trials	7
rescue therapy	7
main trial	7
clinical trialists	7
pandemic may	7
protocol version	7
kcdc guideline	7
tolerable error	7
efficient action	7
different action	7
high mortality	7
trial research	7
mortality rates	7
supply chains	7
healthcare system	7
necrosis factor	7
emerging infectious	7
wolters kluwer	7
type ii	7
nursing homes	7
research subjects	7
descriptive statistics	7
trial management	7
data integrity	7
cannabis use	7
hospitalised patients	7
participants may	7
axillary temperature	7
efficacy trials	7
vaccine candidate	7
confirmed probable	7
patients randomised	7
trials showed	7
see table	7
especially important	7
research infrastructure	7
disease control	7
die within	7
study drugs	7
safety profile	7
china clinical	7
will continue	7
trial sponsor	7
uncorrected axillary	7
cell lines	7
days number	7
working group	7
safety information	7
deviated septum	7
tumor necrosis	7
events will	7
four straws	7
randomizing patients	7
west africa	7
attending physician	7
investigators must	7
target infection	7
principal investigators	7
trial status	7
versus medical	7
adaptive design	7
academic publication	7
trials alongside	7
time bias	7
investigational drug	7
basket trial	7
study period	7
research involving	7
four groups	7
associated pneumonia	7
accelerated approval	7
baseline severity	7
three trials	7
average trial	7
european union	7
malaria chemoprevention	7
sequential monitoring	7
positive results	7
monoclonal antibody	7
rapid research	7
studies may	7
core categories	7
united kingdom	7
without compromising	7
trial date	7
blood samples	7
may occur	7
quality assurance	7
two different	7
incentive payments	7
choice task	7
may help	6
tablet users	6
theoretical sampling	6
mg per	6
human use	6
made efficient	6
ii error	6
investigate whether	6
post hoc	6
without results	6
panel data	6
every week	6
time required	6
red outward	6
invasive mechanical	6
medical sciences	6
minimum dataset	6
causal inference	6
immortal time	6
ethical approval	6
iib trials	6
randomized study	6
conventional treatment	6
completion date	6
th april	6
high quality	6
longitudinal data	6
led clinical	6
oral cholera	6
trial registry	6
originally planned	6
patient information	6
th percentile	6
foraging behaviour	6
trials without	6
direct benefit	6
moderate covid	6
medical care	6
multicentre trial	6
participants compared	6
standard deviation	6
different countries	6
days within	6
trial hydroxychloroquine	6
trial enrollment	6
wedge randomized	6
treating physician	6
trial investigators	6
updated guidelines	6
run length	6
see also	6
adult patients	6
will explore	6
testing chamber	6
geriatric clinical	6
efficacy data	6
causally clear	6
also apply	6
iv twice	6
clinical testing	6
sequential analyses	6
drug companies	6
managing clinical	6
red lines	6
standard treatment	6
patient willingness	6
bubo size	6
clinical effectiveness	6
journal editors	6
green dotted	6
treatment discontinuation	6
plague patients	6
retrospective cohort	6
clinically relevant	6
dotted line	6
tidal volume	6
gender disparities	6
decision making	6
human trial	6
experimental study	6
conventional boundaries	6
coordinator will	6
emulation framework	6
line shows	6
lung disease	6
metastatic colorectal	6
decisions regarding	6
arm trials	6
target population	6
reported outcome	6
management group	6
feasibility study	6
takes place	6
study staff	6
related clinical	6
severe plaque	6
randomised evaluation	6
case time	6
trial findings	6
month intervention	6
potential impact	6
standard supportive	6
treatment trials	6
reviewed publications	6
trials related	6
may influence	6
many patients	6
intravenous immunoglobulin	6
trial identifier	6
age group	6
network analysis	6
several studies	6
research may	6
care professionals	6
medical record	6
reporting parallel	6
clinical protection	6
scientific integrity	6
currently available	6
treat covid	6
ratio reduction	6
national institute	6
calculated based	6
food vs	6
related trials	6
search terms	6
ml kg	6
harmful effect	6
will remain	6
lung function	6
methods used	6
even though	6
saudi arabia	6
nairos trial	6
many trials	6
rapid learning	6
pandemic related	6
patients undergoing	6
trials assessing	6
one study	6
study showed	6
systematic errors	6
expert consensus	6
experimental vaccine	6
arm studies	6
home order	6
many centers	6
proactive prophylaxis	6
useful information	6
fda guidance	6
summary statistics	6
ipad pro	6
new treatment	6
outcome test	6
standard protocol	6
may require	6
medrxiv preprint	6
shows conventional	6
rights reserved	6
trial latency	6
inferiority margin	6
health records	6
also need	6
dexamethasone versus	6
take oral	6
plus interferon	6
different types	6
lupus erythematosus	6
within genv	6
platform trial	6
bushen yiqi	6
medical staff	6
electronic health	6
fatality rate	6
trial coordination	6
single target	6
consort extension	6
cancer xenografts	6
pharmaceutical company	6
recruitment bias	6
randomisation will	6
group randomised	6
small number	6
potential benefits	6
general data	6
information system	6
colon cancer	6
therapeutic agents	6
gender gap	6
nasal septal	6
personal data	6
hypothetical scenario	6
blue line	6
pan troglodytes	6
qualitative research	6
relatively small	6
live intervention	6
baited container	6
volunteer support	6
precision medicine	6
improve patient	6
dexamethasone group	6
cluster randomised	6
stage design	6
futility line	6
collect data	6
academic medicine	6
tcm syndrome	6
monitoring plan	6
licensure trials	6
social networks	6
high incidence	6
outward sloping	6
reporting items	6
month period	6
individual patients	6
cluster randomized	6
multicomponent intervention	6
factors associated	6
health system	6
rcts may	6
may result	6
primary completion	6
sloping red	6
see supplementary	6
gastrointestinal bleeding	6
surgical mask	6
antipsychotic medication	6
preferred reporting	6
subjectively unreasonable	6
time series	6
monitoring visits	6
best practice	6
ethically acceptable	6
patients experiencing	6
median survival	6
across different	6
remote access	6
clinical efficacy	6
sites will	5
consent forms	5
surgical trials	5
maintenance treatment	5
negative correlation	5
study procedures	5
many countries	5
community members	5
samples will	5
unreasonable decisions	5
income countries	5
participating sites	5
study results	5
inward sloping	5
allowed us	5
trials across	5
oral administration	5
monitoring boards	5
informal caregivers	5
interviews will	5
systolic blood	5
adaptive structuration	5
national health	5
new clinical	5
short period	5
will end	5
trial comparing	5
multiple interventions	5
research institutions	5
considered serious	5
quality assessment	5
recruitment intervention	5
different interventions	5
research institute	5
trial using	5
trials research	5
genv may	5
vaccine efficacy	5
trials used	5
event endpoints	5
nose score	5
first time	5
trial reporting	5
will follow	5
preliminary results	5
adjusted life	5
assessment time	5
solidarity trial	5
management arm	5
careful consideration	5
mg orally	5
pandemic influenza	5
plus ciprofloxacin	5
gold standard	5
policy strategy	5
face contact	5
theory method	5
orally twice	5
study objectives	5
national guidelines	5
will use	5
scheduled visits	5
additional sensitivity	5
also used	5
quadrivalent rhesus	5
clinically significant	5
search strategy	5
ethical considerations	5
inflammatory cytokines	5
growth rate	5
trial monitoring	5
tests will	5
service innovation	5
wedge futility	5
supplementary table	5
countries regions	5
resource allocation	5
writing group	5
pain scale	5
first last	5
international guidelines	5
trial team	5
health policy	5
systemic lupus	5
treatment interruptions	5
healthy volunteers	5
hygiene alone	5
septal deviation	5
global pandemic	5
funding bodies	5
study sponsors	5
beneficial effects	5
care group	5
main limitation	5
rhesus rotavirus	5
research projects	5
reference number	5
individual consistency	5
orchid trial	5
inefficient action	5
initial negative	5
individual trials	5
endangered species	5
per trial	5
heart failure	5
mitigation measures	5
trials comparing	5
dosage chloroquine	5
coronavirus infection	5
final manuscript	5
defined based	5
trial reported	5
treatment trial	5
sectional study	5
patient distrust	5
viral infection	5
important role	5
care units	5
observational data	5
potential covid	5
approved drugs	5
ethics approval	5
health services	5
healthcare providers	5
terminology criteria	5
error may	5
first step	5
healthcare products	5
trial drugs	5
study unblinding	5
assessed days	5
routinely collected	5
acoustic information	5
common terminology	5
trial subjects	5
national cancer	5
trials website	5
respiratory tract	5
streptomycin plus	5
median number	5
editorial board	5
viral clearance	5
commons licence	5
remove straws	5
protocol analysis	5
older children	5
improve health	5
corresponding author	5
respiratory protection	5
th stage	5
covid pandemic	5
pregnancy trials	5
safety analyses	5
multicentre trials	5
results suggest	5
trial compared	5
infected patients	5
case growth	5
cohort multiple	5
one patient	5
products regulatory	5
see section	5
low dose	5
protocol items	5
maximum dose	5
patient outcomes	5
literature review	5
clear task	5
mechanically ventilated	5
main outcomes	5
per year	5
trials compared	5
old children	5
pilot study	5
mapping tool	5
awake prone	5
may provide	5
medical community	5
therapeutic efficacy	5
statistical principles	5
treatment regimens	5
advisory unit	5
first presented	5
first two	5
statistical models	5
sloping lines	5
pandemic situation	5
issues related	5
chloroquine phosphate	5
health systems	5
discovery rate	5
imaging follow	5
trial suspension	5
information alone	5
remaining trials	5
study using	5
pandemic effects	5
nasal spray	5
study reports	5
results published	5
care coordination	5
policy evaluations	5
overall trial	5
last years	5
side effect	5
initiated trials	5
five straws	5
rate ratio	5
patient follow	5
trials based	5
case counts	5
project manager	5
risks analyses	5
influenza transmission	5
consent will	5
i trial	5
logistic regression	5
surgical intervention	5
copd exacerbations	5
viral load	5
case numbers	5
health policies	5
different clinical	5
committee will	5
clinically important	5
quintet recruitment	5
general principles	5
label use	5
protocol deviation	5
first stage	5
will report	5
adequately powered	5
study team	5
competing risks	5
calendar time	5
following negative	5
changing task	5
analysis population	5
regulatory agency	5
comparison states	5
stakeholder engagement	5
multiple comparisons	5
findings show	5
tcm herbs	5
relevant research	5
time periods	5
second review	5
within cohorts	5
may continue	5
reporting data	5
chief investigator	5
two separate	5
ethical concerns	5
cancer chemotherapy	5
interactive mapping	5
analysis methods	5
fish oil	5
new treatments	5
related reasons	5
cholera vaccine	5
hospital admission	5
cell lung	5
existing literature	5
might need	5
objectively unreasonable	5
rapidly changing	5
worn continually	5
flexibility across	5
neck cancer	5
performed using	5
working groups	5
quality control	5
pangolins native	5
orphan drugs	5
comparative effectiveness	5
quality evidence	5
significantly reduced	5
promising results	5
infection risk	5
treatment response	5
mashhad university	5
propensity score	5
research designs	5
acute exacerbations	5
transplant patients	5
regulatory bodies	5
patients infected	5
may well	5
patients hospitalized	5
false discovery	5
composite strategy	5
knowledge gap	5
states food	5
mortality rate	5
research network	5
well people	5
many years	5
identified one	5
disease outbreaks	5
data using	5
activated protein	5
disease incidence	5
medical journals	5
novel therapeutic	5
positive patients	5
recruitment rate	5
polio vaccine	5
individual level	5
citation score	5
cov infection	5
paying research	5
sunda pangolins	5
clinically appropriate	5
trial efficacy	5
completion latency	5
used different	5
medical mask	5
pandemic will	5
statistical issues	5
blood tests	5
reassortant vaccine	5
systemic glucocorticoid	5
study nurse	5
adjunctive therapy	5
registration date	5
days alive	5
medical journal	5
nasal blockage	5
testing apparatus	5
chronic rhinosinusitis	5
allocation concealment	5
structuration theory	5
eight trials	5
trials evaluating	5
related deaths	5
nasal septoplasty	4
key elements	4
new trials	4
primary investigator	4
efficient response	4
genv principles	4
trials need	4
information sheet	4
will evaluate	4
ribavirin plus	4
day mortality	4
effects models	4
straw directly	4
trial process	4
prior research	4
target disease	4
specific information	4
care planning	4
physical interventions	4
may increase	4
review will	4
better start	4
hospital discharge	4
action plan	4
voluntary use	4
selection bias	4
may impact	4
person visits	4
high flow	4
well tolerated	4
intravenous curcumin	4
deemed clinically	4
enrolled participants	4
paramount importance	4
received approval	4
likely need	4
product monograph	4
response rate	4
user behaviour	4
give consent	4
better understanding	4
familiar formatting	4
international standards	4
stress scale	4
multinational registry	4
intercurrent events	4
respiratory rate	4
flow diagram	4
demands changed	4
large proportion	4
realistic intervention	4
significance level	4
hubei province	4
research data	4
face masks	4
recruitment period	4
multiple testing	4
trial quality	4
care reduces	4
statistical code	4
generation vaccines	4
therapies may	4
randomly assigned	4
less relevant	4
ring vaccination	4
primary estimand	4
research system	4
standard procedures	4
us fda	4
contralateral turbinate	4
science research	4
treatments due	4
live components	4
received honoraria	4
children made	4
general medical	4
based treatment	4
home visits	4
interrupted time	4
plasma versus	4
index scores	4
supplementary material	4
virtual visits	4
acute generalized	4
trial began	4
recent publications	4
last authorship	4
solid lids	4
difference across	4
betweenness centrality	4
regulatory requirements	4
vaccine pe	4
nan doi	4
removing straws	4
shown apparent	4
resource use	4
full years	4
huang qin	4
technical requirements	4
study protocols	4
must provide	4
olfactory condition	4
early childhood	4
currently ongoing	4
study completion	4
raw data	4
neuropsychiatric symptoms	4
frequency oscillatory	4
patients per	4
trials reporting	4
research protocol	4
inflammatory cytokine	4
respiratory symptoms	4
generalized exanthematous	4
national level	4
modified natural	4
dose mg	4
seamless clinical	4
per dose	4
stepped wedge	4
author role	4
benefit ratio	4
deemed unusable	4
log cases	4
tipping point	4
max mg	4
work closely	4
estimand framework	4
commons attribution	4
utmost importance	4
mental state	4
investigational product	4
rotavirus vaccine	4
data items	4
experimental treatment	4
label non	4
protocol violations	4
academic institutions	4
important outcomes	4
multiple outcomes	4
time constraints	4
live ants	4
administrative datasets	4
basket clinical	4
trials currently	4
plague cases	4
routine clinical	4
named severe	4
ipm will	4
outcomes data	4
nasal outcome	4
clinical course	4
hospital visits	4
group trial	4
hospital setting	4
disease patients	4
error process	4
allocation ratio	4
stop dates	4
public registries	4
condition consisted	4
continuously inform	4
patients receiving	4
bias trials	4
considered significant	4
interferon beta	4
extracted data	4
trial approval	4
label drug	4
five safes	4
volunteer coordinators	4
jia wei	4
study conduct	4
project management	4
mass media	4
acute ischemic	4
influenzae type	4
complete trials	4
controlled vocabularies	4
new therapies	4
probable bubonic	4
across species	4
users appropriate	4
evaluate vaccine	4
may cause	4
results may	4
avoid costly	4
scientific discoveries	4
coronavirus named	4
clinical pharmacology	4
public involvement	4
remote consent	4
mainly driven	4
unmet clinical	4
american trials	4
random effects	4
cochrane handbook	4
related activities	4
spontaneous understanding	4
results show	4
supplementary video	4
north america	4
conducted according	4
significant increase	4
disruptions due	4
larger sample	4
waiving consent	4
oscillatory ventilation	4
provide consent	4
use disorder	4
make use	4
ensure safety	4
rsv severe	4
medical history	4
physician investigators	4
care trials	4
accessed july	4
potential participants	4
living project	4
developing covid	4
manis tricuspis	4
trial activities	4
future work	4
nv rhinospirometer	4
mg twice	4
published trials	4
monitoring room	4
large scale	4
ethical issue	4
relatively low	4
data errors	4
patient reported	4
emergency regulation	4
open label	4
pulmonary surfactant	4
patient management	4
prognostic factors	4
chinese clinical	4
social value	4
dementia plan	4
assessment will	4
rotavirus vaccines	4
size calculation	4
nct number	4
letter serves	4
older persons	4
care time	4
similar viruses	4
cardiovascular trials	4
retrospective study	4
within phase	4
cancer therapies	4
ciprofloxacin alone	4
placebo plus	4
current situation	4
user experience	4
clinical investigation	4
effects model	4
informative censoring	4
efficiency across	4
trial effect	4
review processes	4
identify new	4
pandemic onset	4
medical therapy	4
coordinating centres	4
equal number	4
support trials	4
ritonavir plus	4
will continuously	4
infections may	4
monitoring activities	4
alternative mechanisms	4
across countries	4
analysis set	4
rapidly spreading	4
study populations	4
average latency	4
children born	4
licensure surveillance	4
task completion	4
efficient strategy	4
pandemic periods	4
early stages	4
sequences used	4
trial number	4
study without	4
process will	4
occur due	4
way forward	4
membrane oxygenation	4
trial application	4
growth factor	4
improved survival	4
vaccine side	4
previously published	4
perform meta	4
stable chronic	4
plague season	4
timely manner	4
design features	4
available evidence	4
receive placebo	4
also identified	4
study suggests	4
multiple diseases	4
molecular targets	4
parties involved	4
trial interventions	4
collaborative research	4
large platform	4
put forward	4
ards ali	4
two stages	4
different categories	4
distrust group	4
trials per	4
health practice	4
learning health	4
virus infection	4
genv proposes	4
cumulative network	4
trials working	4
surrogate outcomes	4
primary efficacy	4
patient population	4
comparing two	4
collected health	4
tumor types	4
cognitive impairment	4
industrialized countries	4
find food	4
registered clinical	4
important research	4
allocation will	4
kg iv	4
care research	4
respiratory diseases	4
septoplasty versus	4
med doi	4
recruitment process	4
first case	4
traditional clinical	4
clinical cancer	4
research coordinators	4
recent study	4
data without	4
vaccine adverse	4
patient recruitment	4
specific patient	4
make research	4
chronic idiopathic	4
overcome negative	4
related events	4
macbook pro	4
inferior turbinate	4
less likely	4
potential benefit	4
ischemic stroke	4
safety issues	4
data linkage	4
preserving clinical	4
pharmaceutical interventions	4
may vary	4
cochrane collaboration	4
protection act	4
timely fashion	4
respiratory medicine	4
sponsored clinical	4
investigational site	4
authors read	4
financial support	4
reject realistic	4
mometasone furoate	4
study report	4
cases per	4
qualitative analysis	4
trial intermittent	4
telephone calls	4
interventional clinical	4
one treatment	4
comparative study	4
two authors	4
clarify whether	4
sequence will	4
significant negative	4
tyrosine kinase	4
septic shock	4
data issues	4
total sample	4
may switch	4
cancer treatment	4
care arm	4
european directive	4
data handling	4
time period	4
comparisons across	4
important difference	4
forms will	4
analysis plans	4
nasal high	4
treatment period	4
patients enrolled	4
first trials	4
research studies	4
appropriation literature	4
trial assessments	4
multiple therapies	4
statistical computing	4
without azithromycin	4
first interim	4
biomedical research	4
eudract database	4
event rate	4
consideration may	4
oral corticosteroids	4
patients recruited	4
data cleaning	4
trials date	4
submitting author	4
outcome data	4
trial activation	4
chi shao	4
relative stress	4
cultural values	4
risk patients	4
future pandemics	4
research staff	4
trials group	4
preclinical studies	4
collecting data	4
causal effects	4
economic impact	4
database lock	4
us federal	4
accumulating data	4
new protocol	4
deficient mice	4
care management	4
trial start	4
largest trial	4
laboratory data	4
intervention components	4
us national	4
young children	4
subspecialty designation	4
concomitant medication	4
ethical standards	4
immunological correlate	4
health professionals	4
community health	4
international committee	4
trial dataset	4
cancer institute	4
global health	4
previous research	4
new sites	4
apparent efficacy	4
clinically meaningful	4
effect estimates	4
trials testing	4
will occur	4
primary care	4
senior authorship	4
remdesivir might	4
high contagiousness	4
time point	4
next exacerbation	4
site selection	4
formulas plus	4
expediting dissemination	4
outcome assessors	4
iii rcts	4
similar manner	4
confirmed covid	4
treat analysis	4
evaluate whether	4
superiority hypotheses	4
final cumulative	4
international classification	4
multiple sites	4
educational programs	4
clinical relevance	4
ongoing trial	4
tcm treatment	4
complex interventions	4
open coding	4
specific treatment	4
new approaches	4
based care	4
allocation sequence	4
iii studies	4
small cell	4
experimental treatments	4
authors contributed	4
tested previously	4
examine whether	4
research organization	4
advisory board	4
treatment interventions	4
treatment regimen	4
widely used	4
research oversight	4
fourfold increase	4
children spontaneously	4
species differences	4
across age	4
data sets	4
single trials	4
research funding	4
study nurses	4
surgical arm	4
flow therapy	4
relevant information	4
pangolins may	4
world evidence	4
treatment allocation	4
antibody titre	4
performed remotely	4
study endpoints	4
randomized placebo	4
safety outcome	4
core minimal	4
atopic dermatitis	4
individual trial	4
health data	4
enrolling patients	4
clinical significance	4
kg every	4
trial authors	4
clinical outcome	4
severe atopic	4
health centres	4
qualitative interviews	4
will probably	4
new approach	4
home patients	4
additional days	4
significant effect	4
sometimes known	4
medication review	4
based research	4
incidence value	4
day follow	4
intravenous ciprofloxacin	4
wei bushen	4
exanthematous pustulosis	4
sars coronavirus	4
statistical approach	4
research must	4
sharing platform	4
transplant recipients	4
drug discovery	4
best possible	4
general public	4
conduct trials	4
ciprofloxacin monotherapy	4
receive jwby	4
improve clinical	4
independent living	4
different things	4
rapidly evaluate	4
blind study	4
using cohorts	4
less toxic	4
across phases	4
allergic reactions	4
deviated nasal	4
available information	4
safety reporting	4
simulation study	4
historical data	4
edged sword	4
assess whether	4
effect meta	4
renal function	4
additional information	4
trial staff	4
lessons learned	4
limited resources	4
haemophilus influenzae	4
extracorporeal membrane	4
case fatality	4
will meet	4
every trial	4
average across	3
will work	3
nasal inspiratory	3
truth survival	3
may allow	3
worn intermittently	3
ensure patient	3
depressive symptoms	3
cancer treatments	3
nhs care	3
conditional error	3
trials enrolled	3
naturally occurring	3
higher rates	3
adaptive covid	3
trial id	3
user may	3
biological therapies	3
data unblinding	3
intervention groups	3
enroll patients	3
cancer therapy	3
word level	3
source register	3
whole blood	3
vaccine developed	3
conservative estimate	3
false positive	3
treatment conditions	3
may offer	3
marketing drug	3
disease epidemics	3
crf table	3
current public	3
previous studies	3
used investigational	3
vertical plane	3
figshare project	3
third reviewer	3
particularly relevant	3
coding scheme	3
phone call	3
oral ciprofloxacin	3
solve problems	3
will often	3
conventional medical	3
dwelling persons	3
endpoints may	3
financial incentives	3
will lead	3
live vaccines	3
legal advocate	3
recombinant interferon	3
hydroxychloroquine chloroquine	3
general health	3
bias due	3
tree pangolin	3
unexpected serious	3
probable case	3
suspected unexpected	3
intervention start	3
best interest	3
user acceptance	3
experimental interventions	3
larger numbers	3
variables will	3
trial outcomes	3
trials require	3
poor knowledge	3
primary hypothesis	3
reported deaths	3
ethically permissible	3
weaver ants	3
based interventions	3
trials include	3
ciprofloxacin group	3
involving patients	3
controlled phase	3
restricted access	3
often used	3
baloxavir marboxil	3
gilead sciences	3
target infections	3
spirit statement	3
rotavirus reassortant	3
integrative treatment	3
true emergencies	3
paediatric cancer	3
medications used	3
pvc tube	3
will introduce	3
iii randomized	3
kinase inhibitor	3
based cohort	3
planned sample	3
design elements	3
mometasone nasal	3
review evaluating	3
disease caused	3
level data	3
data patterns	3
post randomisation	3
device trials	3
based mitigation	3
minimal clinically	3
reporting systematic	3
pandemic date	3
note taking	3
induced thrombocytopenia	3
preliminary formulations	3
also inhibits	3
loved one	3
poor performance	3
healthcare settings	3
three phases	3
first configuration	3
earlier studies	3
phone calls	3
virus vaccine	3
practice may	3
sputum samples	3
support systems	3
vaccine strain	3
exclusively enrolled	3
contingency measures	3
press release	3
integrative physicians	3
provide guidance	3
industrysponsored trials	3
master protocol	3
short time	3
among health	3
contingency plans	3
signed consent	3
five patients	3
patients already	3
nhs foundation	3
assessment based	3
overcome disconfirmation	3
appropriate analysis	3
increased use	3
trials safety	3
primary publication	3
ovarian cancer	3
specific questions	3
reflection time	3
two phase	3
successful treatment	3
investigator will	3
writing committee	3
swine flu	3
metal mesh	3
subject study	3
versus days	3
single mg	3
factors related	3
diagnostic test	3
management strategy	3
informant questionnaire	3
neurovascular research	3
clinical results	3
randomized using	3
trial activity	3
prevalent cases	3
adverse reaction	3
incomplete data	3
harmful effects	3
control design	3
i study	3
test apparatus	3
immunogenicity assays	3
drug trial	3
committee approval	3
making sense	3
constraints needed	3
will country	3
even greater	3
trial ends	3
reactive protein	3
users use	3
knowledge translation	3
multiorgan failure	3
readily available	3
free survival	3
include patient	3
appropriate consent	3
psoriatic arthritis	3
medical treatment	3
recent review	3
become increasingly	3
higher risk	3
conjugate vaccine	3
clinical needs	3
intravenous quercetin	3
placebo provided	3
artery disease	3
streptomycin ciprofloxacin	3
ethnic minorities	3
two chinese	3
studies published	3
relevant clinical	3
observational cohort	3
authorship score	3
th immune	3
interstitial lung	3
new york	3
emptive treatment	3
high impact	3
head neck	3
registry analysis	3
basic understanding	3
information technologies	3
may th	3
peak nasal	3
offering payment	3
identifying benefits	3
asian pangolins	3
vaccine immunogenicity	3
sectional analysis	3
normally distributed	3
alopecia areata	3
unprotected healthcare	3
research associate	3
healthy individuals	3
treatment assignment	3
point estimates	3
scientific reports	3
informal care	3
clinical evaluation	3
efficacy outcomes	3
rcts evaluating	3
short form	3
surgical treatment	3
nasal packing	3
implementation research	3
next step	3
changes made	3
funding agencies	3
solution may	3
random effect	3
severe side	3
two reasons	3
patient experience	3
trials use	3
inconclusive results	3
decisions will	3
preventive interventions	3
secondary care	3
assistive technology	3
potential treatment	3
key aspects	3
given time	3
different strategies	3
maximum probability	3
distributive justice	3
author names	3
product development	3
will discuss	3
weighted average	3
significant results	3
clinical investigators	3
term effects	3
tonifying kidney	3
separate data	3
modeling groups	3
maximum follow	3
avoid unnecessary	3
using multiple	3
table presents	3
three days	3
mucocutaneous candidiasis	3
fully informed	3
acceptance model	3
based evidence	3
standardized data	3
must also	3
investigators might	3
site investigators	3
colchicine added	3
simple trials	3
virtual research	3
social sciences	3
innovative clinical	3
study set	3
health science	3
similar participants	3
system use	3
diagnostic tests	3
telehealth may	3
recruitment status	3
general hospital	3
intentional challenge	3
opening remarks	3
global clinical	3
interventions supporting	3
physical contact	3
two home	3
continue investigative	3
may eventually	3
network visualization	3
daily dose	3
received funding	3
cancer drug	3
consent based	3
report will	3
outpatient setting	3
high transmission	3
rapid diagnostic	3
patients may	3
grade unblinding	3
innovative therapies	3
incentives will	3
carefully considered	3
new vaccine	3
related research	3
physician may	3
randomized patients	3
psychiatric symptoms	3
distrust pharmaceutical	3
multiple countries	3
public places	3
patients without	3
active vaccine	3
trial sample	3
future patients	3
one hand	3
therapeutic options	3
external unplanned	3
organizational members	3
universal face	3
stress reduction	3
remain unchanged	3
become available	3
plus lopinavir	3
potentially useful	3
sick people	3
inform best	3
author details	3
adaptive platform	3
human challenge	3
death due	3
arm will	3
pivotal trials	3
personal experience	3
atopic eczema	3
groups will	3
myasthenia gravis	3
will recruit	3
danish national	3
will reduce	3
executive function	3
supportive therapy	3
potential confounders	3
data methods	3
existing treatments	3
within hours	3
inferential statistical	3
paediatric intensive	3
london school	3
eight test	3
care staff	3
gorillas tested	3
trials initiated	3
unproven therapies	3
data processing	3
oral rotavirus	3
candidate vaccines	3
medical practice	3
participating centers	3
previous sections	3
children completed	3
will assess	3
participants per	3
blinded data	3
personnel will	3
data sources	3
learning systems	3
core outcome	3
important data	3
resource shortages	3
current research	3
three sessions	3
icu admission	3
across diverse	3
average efficient	3
participant continues	3
surfactant administration	3
fit among	3
manis pentadactyla	3
vast majority	3
certain diseases	3
record details	3
objectively reasonable	3
intervention arm	3
innovative medicine	3
limited access	3
potent inhibitor	3
will collect	3
previous clinical	3
alone showed	3
single cohort	3
emergency medicine	3
trying times	3
pangolin foraging	3
therapeutic benefit	3
never treated	3
powered multicentre	3
estimated effect	3
nervous system	3
clinical practices	3
guidance documents	3
children across	3
smaller trials	3
trial characteristics	3
significantly impacted	3
medical devices	3
i clinical	3
unrealistic percentages	3
potential health	3
org licenses	3
participants removed	3
registry data	3
children tested	3
tcm formula	3
may limit	3
tract infections	3
uncontrolled trials	3
clinical laboratory	3
exceptional circumstances	3
may conflict	3
one major	3
error learning	3
pharmacologic treatments	3
influenza among	3
based study	3
vs low	3
four control	3
event reporting	3
take advantage	3
top priority	3
prospective clinical	3
across human	3
mass index	3
four elements	3
technological advances	3
weak spot	3
foundation trust	3
concerted efforts	3
pairwise comparisons	3
pradeesh sivapalan	3
media briefing	3
within months	3
data reporting	3
gastric cancer	3
must continue	3
provide written	3
mortality among	3
descriptive study	3
pandemic speed	3
media coverage	3
preventing influenza	3
multicenter trials	3
resveratrol inhibits	3
randomly allocated	3
showed statistically	3
standard approach	3
rich description	3
time interval	3
positive serology	3
demographic data	3
bullous pemphigoid	3
written consent	3
trials indicated	3
trial concept	3
meditation classes	3
children needed	3
includes participants	3
study efficacy	3
missing efficacy	3
data managers	3
secondary outcome	3
comprehensive trial	3
without consent	3
treatment score	3
systematically search	3
high costs	3
methodological issues	3
register unique	3
patient hesitancy	3
adequate sample	3
year follow	3
trial showed	3
hypoxemic respiratory	3
many walls	3
obtaining informed	3
less flexible	3
evaluation will	3
particularly challenging	3
sites per	3
data analyses	3
pandemic setting	3
new zealand	3
report results	3
early due	3
healthy life	3
challenges due	3
collection will	3
tcm granules	3
monitor will	3
empirical investigation	3
first edition	3
greatly impacted	3
provide reassurance	3
antimalarial drug	3
suspected cases	3
public sources	3
glucocorticoid therapy	3
case basis	3
better understand	3
network study	3
will depend	3
pandemic due	3
novel drugs	3
pangolin manis	3
potential future	3
specialist health	3
relevant regulations	3
term follow	3
best interests	3
plague will	3
coordination mechanisms	3
serious side	3
trial adaptations	3
taking part	3
past months	3
rcts assessing	3
trial safety	3
first detected	3
effect sizes	3
well beyond	3
since i	3
potentially eligible	3
consent always	3
different treatment	3
trials must	3
adaptive randomisation	3
start date	3
additional data	3
adult respiratory	3
prevent influenza	3
curve crossed	3
treating clinician	3
diseases outbreaks	3
one per	3
investigative treatments	3
irb approval	3
immunosuppressed patients	3
differences across	3
functional assessment	3
i ii	3
vaccine cvd	3
family members	3
permuted blocks	3
user involvement	3
operational issues	3
either individual	3
trial drug	3
planned sensitivity	3
immunological correlates	3
staff involved	3
grant application	3
selective coding	3
care facilities	3
respiratory virus	3
yet another	3
trials take	3
future study	3
additional challenges	3
trial infrastructure	3
acute hypoxemic	3
second phase	3
patient profile	3
data extraction	3
chemotherapy drugs	3
last authors	3
per country	3
new patients	3
severe dementia	3
plague around	3